[1]
|
Saidi, R.F. (2012) Current Status of Liver Transplantation. Archives of Iranian Medicine, 15, 772-776.
|
[2]
|
Lacaille, F. (2012) Liver Transplantation and Liver Cell Transplantation. Clinics and Research in Hepatology and Gastroenterology, 36, 304-307. https://doi.org/10.1016/j.clinre.2012.03.029
|
[3]
|
Atria, M., Silva, M.A. and Mirza, D.F. (2008) The Marginal Liver Donor—An Update. Transplant International, 21, 713-724. https://doi.org/10.1111/j.1432-2277.2008.00696.x
|
[4]
|
Nadig, S.N., Bratton, C.F. and Karp, S.J. (2007) Marginal Donors in Liver Transplantation: Expanding the Donor Pool. Journal of Surgical Education, 64, 46-50. https://doi.org/10.1016/j.cursur.2006.08.001
|
[5]
|
Sherlock, S. (1983) Acute Fatty Liver of Pregnancy and the Microvesicular Fat Diseases. Gut, 24, 265-269.
https://doi.org/10.1136/gut.24.4.265
|
[6]
|
Selzner, M. and Clavien, P.A. (2001) Fatty Liver in Liver Transplanta-tion and Surgery. Seminars in Liver Disease, 21, 105-114. https://doi.org/10.1055/s-2001-12933
|
[7]
|
Briceno, J., Solórzano, G. and Pera, C. (2000) A Proposal for Scoring Marginal Liver Grafts. Transplant International, 13, S249-S252. https://doi.org/10.1111/j.1432-2277.2000.tb02029.x
|
[8]
|
Imber, C.J., St. Peter, S.D., Handa, A., et al. (2002) Hepatic Steatosis and Its Relationship to Transplantation. Liver Transplantation, 8, 415-423. https://doi.org/10.1053/jlts.2002.32275
|
[9]
|
Adam, R., Reynes, M., Johann, M., et al. (1991) The Outcome of Steatotic Grafts in Liver Transplantation. Transplantation Proceedings, 23, 1538-1540.
|
[10]
|
Spitzer, A.L., Lao, O.B., Dick, A.A., et al. (2010) The Biopsied Donor Liver, Incorporating Macrosteatosis into High-Risk Donor Assessment. Liver Transplantation, 16, 874-884. https://doi.org/10.1002/lt.22085
|
[11]
|
Fishbein, T.M., Fiel, M.I., Emre, S., et al. (1997) Use of Livers with Microvessicular Fat Safely Expands the Donor Pool. Transplantation, 64, 248-251. https://doi.org/10.1097/00007890-199707270-00012
|
[12]
|
Strasberg, S.M., Howard, T.K., Molmenti, E.P., et al. (1994) Selecting the Donor Liver: Risk Factors for Poor Function after Orthotopic Liver Transplantation. Hepatology, 20, 829-838. https://doi.org/10.1002/hep.1840200410
|
[13]
|
Loinaz, C. and Gonzlez, E.M. (2000) Marginal Donors in Liver Transplantation. Hepatogastroenterology, 47, 256-263.
|
[14]
|
Perera, M.T. and Bramhall, S.R. (2011) Current Status and Recent Advances of Liver Transplantation from Donation after Cardiac Death. World Journal of Gastrointestinal Surgery, 3, 167-176. https://doi.org/10.4240/wjgs.v3.i11.167
|
[15]
|
Lee, K.W., Simpkins, C.E., Montgomery, R.A., et al. (2006) Factors Affecting Graft Survival after Liver Transplantation from Donation after Car-diac Death Donors. Transplantation, 82, 1683-1688.
https://doi.org/10.1097/01.tp.0000250936.73034.98
|
[16]
|
Abt, P.L., Praestgaard, J., West, S., et al. (2014) Donor Hemodynamic Profile Presages Graft Survival in Donation after Cardiac Death Liver Transplantation. Liver Trans-plantation, 20, 165-172. https://doi.org/10.1002/lt.23777
|
[17]
|
Totsuka, E., Fung, J., Lee, M., Ishi, T., Umehara, M., et al. (2002) Influence of Cold Ischemia Time and Graft Transport Distance on Postoperative Outcome in Human Liver Transplantation. Surgery Today, 32, 792-799.
https://doi.org/10.1007/s005950200152
|
[18]
|
Nguyen, J.H., Bonatti, H., Dickson, R.C., et al. (2009) Long-Term Outcomes of Donation after Cardiac Death Liver Allografts from a Single Center. Clinical Transplantation, 23, 168-173.
https://doi.org/10.1111/j.1399-0012.2009.00968.x
|
[19]
|
Fernandez-Merino, F.J., Nuno-Garza, J., Lopez-Hervas, P., et al. (2003) Donor Age as a Risk Factor for Patient Survival in the Liver Transplant. Transplantation Proceedings, 35, 1795-1797.
https://doi.org/10.1016/S0041-1345(03)00594-3
|
[20]
|
Detry, O., Derover, A., Meurisse, N., et al. (2014) Donor Age as a Risk Factor in Donation after Circulatory Death Liver Transplantation in a Controlled Withdrawal Protocol Programme. British Journal of Surgery, 101, 784-792.
https://doi.org/10.1002/bjs.9488
|
[21]
|
Loggi, E., Micco, L., Ercolani, G., et al. (2012) Liver Transplantation from Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool. Journal of Hepatology, 56, 579-585.
https://doi.org/10.1016/j.jhep.2011.09.016
|
[22]
|
Testa, G., Goldstein, R.M., Netto, G., et al. (1998) Long-Term Outcome of Patients Transplanted with Livers from Hepatitis C-Positive Donors. Transplantation, 65, 925-929. https://doi.org/10.1097/00007890-199804150-00011
|
[23]
|
Briceno, J., Marchal, T., Padillo, J., et al. (2002) In-fluence of Marginal Donors on Liver Preservation Injury. Transplantation, 74, 522-526. https://doi.org/10.1097/00007890-200208270-00015
|
[24]
|
Saab, S., Chang, A.J., Comulada, S., et al. (2003) Outcomes of Hepatitis C and Hepatitis B Core Antibody-Positive Grafts in Orthotopic Liver Transplantation. Liver Transplantation, 9, 1053-1061.
https://doi.org/10.1053/jlts.2003.50208
|
[25]
|
Mangus, R.S., Fridell, J.A., Vianna, R.M., et al. (2010) Severe Hy-pernatremia in Deceased Liver Donors Doas Not Impact Earl Transplant Outcome. Transplantation, 90, 438-443. https://doi.org/10.1097/TP.0b013e3181e764c0
|
[26]
|
刘现忠, 王轩. 边缘性供肝对肝移植术后肝功能影响及对策[J]. 中国普通外科杂志, 2010, 19(7): 809-812.
|
[27]
|
Kauffman, H.M., Cherikh, W.S., McBride, M.A., et al. (2007) Deceased Donors with a Past History of Malignancy: An Organ Procurement and Transplantation Network/United Network for Organ Sharing Update. Transplantation, 84, 272-274. https://doi.org/10.1097/01.tp.0000267919.93425.fb
|
[28]
|
Goldaracena, N., Qui onez, E., M dez, P., et al. (2012) Extremely Marginal Liver Grafts from Deceased Donors Have Outcome Similar to Ideal Grafts. Transplantation Pro-ceedings, 44, 2219-2222.
https://doi.org/10.1016/j.transproceed.2012.07.113
|
[29]
|
Cameron, A. and Busuttil, R.W. (2005) AASLD/ILTS Transplant Course: Is There an Extended Donor Suitable for Everyone? Liver Transplantation, 11, S2-S5. https://doi.org/10.1002/lt.20596
|
[30]
|
Adam, R., Reynes, M., Bao, Y., et al. (1993) Impact of Glycogen Content of the Donor Liver in Clinical Liver Transplantation. Transplantation Proceedings, 25, 1536-1537.
|
[31]
|
Olmedilla, L., Lisbona, C.J., Pérez-Peña, J.M., et al. (2016) Early Measurement of Indocyanine Green C1earance Accurately Predicts Short-Term Outcomes after Liver Transplantation. Transplantation, 100, 613-620.
https://doi.org/10.1097/TP.0000000000000980
|